June 3, 2024
ASCO 2024 (Adjuvant melanoma)
Download
SEC Filings
Investor FAQs
Information Request Form
Ir@modernatx.com
Unsubscribe
Investor overview
Press releases
Media kit
All Media
Blogs
Strategic collaborators
Company culture
People behind the science
Join our team
New venture labs
© 2025 Moderna, Inc.
